<div id="readability-page-1" class="page">11:05 AM EDT, 05/11/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts opened the week on a flat note Monday morning, edging 0.08% higher to 1,835.34 on the S&amp;P Europe Select ADR Index.From continental Europe, the gainers were led by semiconductor company Sequans Communications ( SQNS ) and biopharmaceutical company Cellectis ( CLLS ) , which advanced 8.1% and 6.3% respectively. They were followed by biopharmaceutical company DBV Technologies ( DBVT ) and telecommunications company Ericsson (ERIC), which increased 4.9% and 3.2% respectively.The decliners from continental Europe were led by consumer goods company Unilever ( UL ) and biopharmaceutical company Grifols ( GRFS ) , which fell 1.9% and 1.3% respectively. They were followed by internet browser company Opera (OPRA) and accommodations booking site trivago (TRVG), which were down 1% each.The gainers from the UK were led by cruise line operator Carnival (CUK) and pharmaceutical company Silence Therapeutics ( SLN ) , which rose 6.6% and 4.7% respectively. They were followed by biotech firm Autolus Therapeutics ( AUTL ) and biopharmaceutical company Amarin ( AMRN ) , which were up 3.9% and 3.4% respectively.The decliners from the UK and Ireland were led by biopharmaceutical companies Akari Therapeutics ( AKTX ) and Mereo BioPharma Group ( MREO ) , which lost 10% and 7.3% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and software firm Endava ( DAVA ) , which dropped 5.8% and 2.2% respectively. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

MREO

SQNS

CLLS

GRFS

European equities traded in the US as American depositary receipts opened the week flat, edging up 0.08% to 1,835.34 on the S&P Europe Select ADR Index. Notable gainers included Sequans Communications (+8.1%) and Cellectis (+6.3%), while Unilever (-1.9%) and Grifols (-1.3%) were among the decliners. In the UK, Carnival rose 6.6% and Silence Therapeutics 4.7%, while Akari Therapeutics fell 10% and Mereo BioPharma Group 7.3%.

Fidelity

Mereo Biopharma

Carnival

Sequans Comm 

Cellectis

Silence Therapeutics

GRIFOLS SA

Unilever

DBV Tech

Ericsson

Unilever PLC

Opera

Trivago NV

Autolus Therapeutics

Amarin

Akari Therap

Biodexa Pharmaceuticals

Endava

Carnival plc

European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading